The UK Life Sciences Industrial Strategy should be required reading for every healthcare leader in the UK. It makes clear that the NHS must be an active participant with industry in delivering the shared objective of outstanding patient outcomes.
The ABPI has produced this sourcebook to support pharmaceutical companies in working successfully and collaboratively with patients and patient organizations.
Pharmaceutical companies are doing everything in their power to avoid disruption to the supply of medicines in all Brexit scenarios. This includes increasing stocks of medicine in the UK, changing supply routes, transferring medicine licenses and duplicating testing in the EU.
The UK has robust measures in place to ensure that medicines and vaccines are both clinically and cost effective before they can be used in the NHS.
Illness never sleeps. It grows, mutates and causes pain and suffering. Disease never takes a break, so neither do we. Because people fighting disease deserve the best chance to live. We won’t rest until people around the world see a brighter tomorrow.
Millions of people wouldn't be here today if it wasn't for life-changing science. And many more wouldn't be living the lives they do.
26 June 2019
A written ministerial statement from the Cabinet Office has been published this afternoon, along with a letter giving an update on the Government’s 'no deal' planning and guidance.
25 June 2019
The Office for Life Sciences has today published its annual Life Science Competitiveness Indicators, which highlight the importance of the Industry to the UK economy.
23 June 2019
Outgoing Chief Medical Officer Professor Dame Sally Davies has been named as UK Special Envoy on antimicrobial resistance (AMR), working across all sectors including includes health, agriculture and the environment to tackle the global health threat.
19 June 2019
The NHS Confederation and the ABPI have today published a new report to help the NHS and life sciences industry work more closely together.
20 June 2019
Jamie Harvey from AstraZeneca is one of around 40,000 people employed in medicines manufacturing in the UK. He gives his perspective on what it’s like to be an apprentice in the sector.
05 June 2019
Dr Richard Torbett provides an ABPI view on medicines pricing in the UK and the current situation between NHS England and Vertex on access to Orkambi for Cystic Fibrosis patients